The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their ...

Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...

Presentation Operator Good morning, and welcome to UnitedHealth Group Fourth Quarter and Full Year 2024 Earnings Conference ...

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in ...

The new administration is likely to take significant actions that will impact employer-sponsored health insurance and federal ...

The decision by Trump’s team to tap Heather Flick as HHS chief of staff signals an effort to keep closer watch on the ...

As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are ...